The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports the company's current earnings are โฌ33.42 Billion. a decrease over its 2023 earnings that were of โฌ6.84 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 | โฌ4.01 B | -41.32% |
2023 | โฌ6.84 B | 6.93% |
2022 | โฌ6.40 B | 9.63% |
2021 | โฌ5.83 B | -17.61% |
2020 | โฌ7.08 B | -11% |
2019 | โฌ7.96 B | -4.26% |
2018 | โฌ8.31 B | -0.54% |
2017 | โฌ8.36 B | 4.74% |
2016 | โฌ7.98 B | 14.85% |
2015 | โฌ6.95 B | 42.85% |
2014 | โฌ4.86 B | 6.08% |
2013 | โฌ4.58 B | 5.11% |
2012 | โฌ4.36 B | 20.7% |
2011 | โฌ3.61 B | -21.95% |
2010 | โฌ4.63 B | 2.17% |
2009 | โฌ4.53 B | -0.88% |
2008 | โฌ4.57 B | 32.54% |
2007 | โฌ3.45 B | -1.47% |
2006 | โฌ3.50 B | -17.42% |
2005 | โฌ4.24 B | 43.39% |
2004 | โฌ2.95 B | 7% |
2003 | โฌ2.76 B | -550.38% |
2002 | -โฌ0.62 Billion | -141.78% |
2001 | โฌ1.46 B | 0.72% |
2000 | โฌ1.45 B | 6.9% |
1999 | โฌ1.36 B | 27.92% |
1998 | โฌ1.06 B | 42.14% |
1997 | โฌ0.75 B | -10.49% |
1996 | โฌ0.83 B | 21.14% |
1995 | โฌ0.69 B | 34.99% |
1994 | โฌ0.51 B | -0.66% |
1993 | โฌ0.51 B | 5.22% |
1992 | โฌ0.49 B | 256.55% |
1991 | โฌ0.13 B | 549.79% |
1990 | โฌ21.17 M | -157.58% |
1989 | -โฌ36.78 Million | -410.29% |
1988 | โฌ11.85 M | -20.47% |
1987 | โฌ14.9 M | 263.83% |
1986 | โฌ4.09 M | 487.5% |
1985 | โฌ0.69 M | -112.7% |
1984 | -โฌ5.5 Million |